Current partner codePEPTIDESDE
PeptideStat
Menu

Vendors

Compare pricesVendor directoryVendor reviewsDiscount codesLab tests & COAs

Research

ResearchDatabaseClinical trials

Tools

All calculatorsReconstitutionAccumulationUnit converterPeptide chemistry

Recruitment-status index

WithdrawnPeptide Trials.

Explore every peptide study grouped under withdrawn in the local registry snapshot. Check the source record before relying on recruitment status, because registry entries can change.

Studies
64
Recruiting
0
Completed
0
Results posted
0
Countries
21
Avg enrollment
0

Velocity

Withdrawn trials by start year

Study start year · indexed snapshot

5431020062006: 1 trials2007: 3 trials2008: 3 trials2009: 3 trials20102010: 2 trials2011: 4 trials2012: 2 trials2013: 2 trials20142014: 3 trials2015: 5 trials2016: 4 trials2017: 5 trials20182018: 2 trials2019: 2 trials2020: 4 trials2021: 4 trials20222022: 1 trials2023: 1 trials2024: 5 trials2025: 4 trials20262026: 4 trials

Development

Trials by phase

Early Phase 12
Phase 110
Phase 219
Phase 312
Phase 49

Industry

Leading sponsors

Ipsen3
Foresee Pharmaceuticals Co., Ltd.2
GlaxoSmithKline2
Novo Nordisk2
RegeneRx Biopharmaceuticals, Inc.2
Altor BioScience1
GlyPharma Therapeutics1
Hoffmann-La Roche1

Therapeutic areas

Condition groups

Weight loss5
Inflammation4
Type 2 diabetes3
Brain health2
Pain2
Longevity1

Compound leaders

Most represented peptides.

01Pramlintide502Secretin503Bivalirudin404Lanreotide405Pasireotide406Thymosin Alpha-1407Tesamorelin308Triptorelin309Abaloparatide210Albiglutide211Cagrilintide212Degarelix2

Study explorer

Search this collection.

64 matching studies